Loading…

Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL‐like T‐cell lymphoma: A spectrum of T‐cell neoplasia

Thirty cases of immunologically determined and histologically diagnosed immunoblastic lymphadenopathy (IBL), angioimmunoblastic lymphadenopathy (AILD), and IBL‐like T‐cell lymphoma were clinicopathologically reviewed. Clinical manifestations and laboratory findings did not reveal significant differe...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1986-11, Vol.58 (10), p.2224-2232
Main Authors: Watanabe, Shaw, Sato, Yuichi, Shimoyama, Masanori, Minato, Keisuke, Shimosato, YUKIO
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thirty cases of immunologically determined and histologically diagnosed immunoblastic lymphadenopathy (IBL), angioimmunoblastic lymphadenopathy (AILD), and IBL‐like T‐cell lymphoma were clinicopathologically reviewed. Clinical manifestations and laboratory findings did not reveal significant differences in these three groups. IBL, AILD, and IBL‐like T‐cell lymphoma showed a spectrum of histologic changes, in which proliferation of pale cells was a critical diagnostic point for the histologic malignancy. Immunostaining for their subsets revealed that 3 of 21 cases showed T4+ phenotype and the remaining 19 cases showed T8+ phenotype. Three of seven immunohistochemically determined T8+ cases simultaneously expressed Leu7+ phenotype. The latter cells were consistent with large granular lymphocytes in one case, but no clinicopathological differences from the other T8+ cases were present. IBL and AILD were considered to be T‐cell malignancies, which show a spectrum of histologic features from T‐cell dysplasia to peripheral T‐cell lymphoma (IBL‐like T‐cell lymphoma). Despite intensive chemotherapy, prognosis was poor in T8+ cases of which half of the patients died within 1 year. T4+ cases showed better prognosis, but a higher incidence of synchronous second primary cancers was recognized.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19861115)58:10<2224::AID-CNCR2820581011>3.0.CO;2-3